RISK FACTORS FOR BREAKTHROUGH COVID-19 IN 14,713 UK ADULTS AFTER PRIMARY AND BOOSTER DOSES OF SARS-COV-2 VACCINES
Volume
77
Pagination
A25 - A26
DOI
10.1136/thorax-2022-BTSabstracts.43
ISSN
0040-6376
Metadata
Show full item recordAuthors
Vivaldi, G; Jolliffe, DA; Holt, H; Talaei, M; Tydeman, F; Shaheen, SO; Martineau, ARCollections
- Centre for Immunobiology [1121]